Please login to the form below

Not currently logged in
Email:
Password:

EMA’s head of human medicines development steps down

Patrick Le Courtois leaves regulator after 16 years

EMA Patrick Le CourtoisThe European Medicines Agency (EMA) has announced that Dr Patrick Le Courtois is to retire as head of human medicines development and evaluation.

Dr Le Courtois (pictured right) will leave the regulatory body later this month after 16 years at the EMA, having joined in 1997 as human medicinal products head of unit support.

He then served as head of new chemical substance and head of scientific advice and orphan drugs before being appointed to the regulator's senior management team in 2001 when he became head of pre-authorisation evaluation of medicines for human use. He has been in his current position since 2009.

"Patrick's retirement brings to a close a remarkable career of 16 years of service to the Agency,” said Guido Rasi, executive director of the EMA.

“I would like to formally thank Patrick for his innumerable contributions to public health and for his resolute commitment to helping build a strong European medicines system.”

Prior to joining the EMA, Dr Le Courtois was head of oncology, anti-infectives and coordination of European Procedures at the regulatory agency for France having spent several years in the country's ministry of health.

The EMA did not say if a successor was lined up to replace Dr Le Courtois.

2nd August 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics